Naveen Singh is a highly experienced cancer researcher with a diverse professional background. Dr. Singh has studied and worked at reputable institutions such as the University of Pennsylvania, the University of Texas Southwestern Medical Center, and Indiana University School of Medicine. Dr. Singh's research focuses on DNA repair pathways, drug metabolizing enzymes, and enhancing synthetic lethality of anti-cancer drugs. Prior to his academic career, Dr. Singh gained eight years of industrial experience in rDNA and polysaccharide conjugate vaccines. He also has experience as an Executive Officer - Quality Control at Serum Institute of India Limited and a Senior Analyst - Quality Control at Shantha Biotechnics Limited. Dr. Singh has earned a Doctor of Philosophy (PhD) in Biochemistry from New Mexico State University and a Master of Science (M.S.) in Biochemistry from Acharya Nagarjuna University.